Scholarlink

<p>Various therapeutic approaches to reduce ischemic brain injuries have been somewhat ineffective. Thymoquinone (TQ), a bioactive compound in <i>Nigella sativa</i>, exhibits anti-inflammatory and antioxidant properties. Transcranial photobiomodulation (tPBM), also known as low-level laser therapy (LLLT), has neuroprotective effects by modulating inflammatory and apoptotic pathways. This study investigated whether the administration of TQ as a candidate for combination therapy with tPBM could reduce ischemic brain injuries. Eighty-five <i>Wistar</i> male rats were randomly assigned to five groups: sham, MCAO, TQ, tPBM, and TQ + tPBM. The MCAO group was subjected to middle cerebral artery occlusion (MCAO) surgery. The sham group underwent surgery without filament insertion. The TQ group received 15&#xa0;mg/kg of intraperitoneal TQ immediately after filament removal. The tPBM group was treated using a Photino brain laser probe (810&#xa0;nm, 8 mW, and 30.6&#xa0;J/cm²), which was applied to the cerebral surface of the rats in three sessions, each lasting 2&#xa0;min. At 24&#xa0;h After reperfusion, neurological deficit scores (NDS), infarct volume (IV), and brain edema in cortex, piriform cortex-amygdala, as well as the striatum of the rat brain were assessed. Histopathological parameters and brain-derived neurotrophic factor (<i>BDNF</i>) gene expression were also evaluated. The TQ + tPBM group significantly reduced NDS, IV, and brain edema compared to the MCAO group. Increased <i>BDNF</i> gene expression and decreased pyknotic cells were also observed in the TQ + tPBM group. The post-treatment administration of TQ combined with tPBM (in the short term) indicated an enhanced combined effect in reducing ischemic brain damage, potentially through <i>BDNF</i> upregulation.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Enhanced combined effect of thymoquinone and transcranial photobiomodulation on cerebral ischemia-induced injuries in animal model

  • 期刊论文

  • 发表日期：

    2026年4月20日

查看全文
  • Zohre Fendereski Jaz,
  • Mohammadreza Bigdeli,
  • Sepideh Khaksar,
  • S. Maryam Noorbakhsh

摘要

Various therapeutic approaches to reduce ischemic brain injuries have been somewhat ineffective. Thymoquinone (TQ), a bioactive compound in Nigella sativa, exhibits anti-inflammatory and antioxidant properties. Transcranial photobiomodulation (tPBM), also known as low-level laser therapy (LLLT), has neuroprotective effects by modulating inflammatory and apoptotic pathways. This study investigated whether the administration of TQ as a candidate for combination therapy with tPBM could reduce ischemic brain injuries. Eighty-five Wistar male rats were randomly assigned to five groups: sham, MCAO, TQ, tPBM, and TQ + tPBM. The MCAO group was subjected to middle cerebral artery occlusion (MCAO) surgery. The sham group underwent surgery without filament insertion. The TQ group received 15 mg/kg of intraperitoneal TQ immediately after filament removal. The tPBM group was treated using a Photino brain laser probe (810 nm, 8 mW, and 30.6 J/cm²), which was applied to the cerebral surface of the rats in three sessions, each lasting 2 min. At 24 h After reperfusion, neurological deficit scores (NDS), infarct volume (IV), and brain edema in cortex, piriform cortex-amygdala, as well as the striatum of the rat brain were assessed. Histopathological parameters and brain-derived neurotrophic factor (BDNF) gene expression were also evaluated. The TQ + tPBM group significantly reduced NDS, IV, and brain edema compared to the MCAO group. Increased BDNF gene expression and decreased pyknotic cells were also observed in the TQ + tPBM group. The post-treatment administration of TQ combined with tPBM (in the short term) indicated an enhanced combined effect in reducing ischemic brain damage, potentially through BDNF upregulation.

Graphical Abstract